Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
|
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) > Segments
|
|
| Manufacturing |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-25-21 | Dec-26-20 | Dec-28-19 | Dec-29-18 | Dec-30-17 | Dec-31-16 | Dec-26-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 789.6 | 742.5 | 515.4 | 465.1 | 429.6 | 384.0 | | 280.7 |
| Revenue growth | 6.3% | 44.1% | 10.8% | 8.3% | 11.9% | | | 9.7% |
| EBITDA | 245.2 | 296.2 | 210.1 | 172.0 | 160.0 | 149.7 | 130.1 | 94.4 |
| EBITDA margin | 31.0% | 39.9% | 40.8% | 37.0% | 37.2% | 39.0% | | 33.6% |
| Depreciation and amortization | 73.0 | 46.2 | 25.9 | 23.6 | 22.5 | 22.9 | 25.6 | 18.1 |
| EBIT | 172.2 | 250.1 | 184.2 | 148.5 | 137.4 | 126.8 | 104.6 | 76.3 |
| EBIT margin | 21.8% | 33.7% | 35.7% | 31.9% | 32.0% | 33.0% | | 27.2% |
| Non-recurring charges | 5.1 | 3.7 | 2.7 | 3.0 | 1.2 | 2.9 | 0.0 | 1.6 |
| |
| Capital expenditures | 87.1 | 58.9 | 26.3 | 23.6 | 23.3 | 15.2 | 12.2 | 9.8 |
| |
| Revenue Mix | 19.9% | 21.0% | 17.6% | 17.7% | 19.0% | 20.7% | | 20.6% |
| EBIT Mix | 25.7% | 41.8% | 41.9% | 41.4% | 41.1% | 43.0% | 44.0% | 36.2% |
|